Published on 1 Apr 2024 on Insider Monkey via Yahoo Finance
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript March 28, 2024
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12. DARE isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company’s Fourth Quarter Financial Results and to provide a General Business Update. This call is being recorded. My name is Lisa, and I will be your operator today. With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer; and MarDee Haring-Layton, Chief Accounting Officer. Ms. Johnson, please proceed.